WeVote

Bill

Bill

S 586

Flood Insurance Affordability Tax Credit Act

119th Congress Introduced by Cory Booker and 1 co-sponsor

Bill S 586 mandates Medicaid and private insurers to respond to oncology pre-authorization claims within five business days, ensuring timely access to vital treatments.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 586

Summary of Bill S 586

Bill Overview

  • Bill Number: S 586
  • Title: Mandated Response Time for Pre-Authorization Claims in Oncology
  • Status: Referred to Insurance Committee
  • Introduced Date: January 08, 2025
  • Classification: Legislative Bill

Purpose and Intent

Bill S 586 aims to improve the efficiency and timeliness of healthcare delivery for oncology patients by establishing a mandated response window for pre-authorization claims. The bill specifically targets both Medicaid and private insurance providers, requiring them to respond to pre-authorization requests made by physicians within a set timeframe.

Key Provisions

  • Response Timeframe: The bill mandates that both Medicaid and private insurers must respond to pre-authorization claims for testing and/or treatments within five business days.
  • Applicability: This requirement applies specifically to claims made on behalf of oncology patients, ensuring that they receive timely access to necessary medical interventions.

Impact

  • Oncology Patients: The primary beneficiaries of this bill are oncology patients who often require urgent and timely access to treatments and tests. The mandated response time is expected to reduce delays in care, potentially improving health outcomes.
  • Healthcare Providers: Physicians treating oncology patients will have a clearer expectation of when to expect responses from insurers, allowing for better planning and patient management.
  • Insurance Providers: Medicaid and private insurers will need to adjust their operational processes to comply with the new mandated timeframe, which may involve changes in staffing or technology to ensure timely responses.

Procedural Aspects

  • Current Status: As of January 8, 2025, the bill has been referred to the Insurance Committee for further consideration.
  • Related Legislation: This bill is related to prior-session Bill S 9858 and has a companion bill, A 1462, which may address similar issues in the Assembly.

Conclusion

Bill S 586 represents a significant step towards enhancing the responsiveness of insurance providers in the oncology sector. By establishing a clear timeframe for pre-authorization responses, the bill seeks to alleviate some of the barriers that oncology patients face in accessing timely care. The ongoing legislative process will determine the final outcome and implementation of this important measure.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.